Cargando…
Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325041/ https://www.ncbi.nlm.nih.gov/pubmed/34331616 http://dx.doi.org/10.1007/s10072-021-05495-6 |
_version_ | 1783731488114606080 |
---|---|
author | Habek, Mario |
author_facet | Habek, Mario |
author_sort | Habek, Mario |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8325041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-83250412021-08-02 Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis Habek, Mario Neurol Sci Covid-19 Springer International Publishing 2021-07-31 2021 /pmc/articles/PMC8325041/ /pubmed/34331616 http://dx.doi.org/10.1007/s10072-021-05495-6 Text en © Fondazione Società Italiana di Neurologia 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Covid-19 Habek, Mario Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis |
title | Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis |
title_full | Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis |
title_fullStr | Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis |
title_full_unstemmed | Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis |
title_short | Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis |
title_sort | chickenpox and asymptomatic covid-19 after first cycle of alemtuzumab for multiple sclerosis |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325041/ https://www.ncbi.nlm.nih.gov/pubmed/34331616 http://dx.doi.org/10.1007/s10072-021-05495-6 |
work_keys_str_mv | AT habekmario chickenpoxandasymptomaticcovid19afterfirstcycleofalemtuzumabformultiplesclerosis |